ClosedOpportunity HT942526OCRPCTA

DoW Ovarian Cancer, Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Ovarian Cancer, Clinical Trial Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was October 1, 2026. Total estimated funding is $5.6M across about 2 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Posted: May 4, 2026
Close date: Oct 1, 2026
Archive date: Oct 31, 2026
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $5,600,000
Expected awards: 2
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Who can apply

Unrestricted (any entity type)

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.

Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Christopher Meinberg Grantor
help@ebrap.org
3016192657

Quick answers

Who is eligible to apply for “DoW Ovarian Cancer, Clinical Trial Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Ovarian Cancer, Clinical Trial Award”?

Per the notice, total estimated program funding is $5,600,000 and the agency expects to make about 2 awards.

How do I apply for “DoW Ovarian Cancer, Clinical Trial Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526OCRPCTA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 6 daysALN 12.420